Does metformin affect the kidneys
Pro Research Analysisby 
Searched over 200M research papers
The Impact of Metformin on Kidney Function
Introduction to Metformin and Kidney Health
Metformin is a widely used medication for managing type 2 diabetes mellitus (T2DM). Beyond its glucose-lowering effects, recent research has explored its potential impact on kidney health, particularly in conditions such as acute kidney injury (AKI), chronic kidney disease (CKD), and diabetic kidney disease (DKD).
Metformin and Acute Kidney Injury (AKI)
Several studies have indicated that metformin may have protective effects against AKI. In various animal models, metformin has been shown to protect renal tubular cells from inflammation, apoptosis, and oxidative stress through the activation of AMP-activated protein kinase (AMPK) . These findings suggest that metformin could be beneficial in preventing or mitigating AKI.
Metformin and Chronic Kidney Disease (CKD)
Metformin's role in CKD has been extensively studied. Clinical and preclinical data suggest that metformin can ameliorate CKD progression by reducing renal inflammation, oxidative stress, and fibrosis 245. In a study involving non-diabetic rats with adenine-induced CKD, metformin significantly improved renal function and reduced markers of kidney damage . Additionally, metformin has been associated with lower all-cause mortality and reduced progression to end-stage renal disease (ESRD) in patients with CKD 410.
Metformin and Diabetic Kidney Disease (DKD)
In patients with DKD, metformin has shown promise in reducing renal inflammation and oxidative stress, which are key contributors to disease progression . Clinical studies have demonstrated that metformin use is associated with lower mortality rates and a reduced risk of ESRD in patients with DKD . However, caution is advised when prescribing metformin to patients with advanced CKD due to the potential risk of lactic acidosis, although this risk appears to be low 510.
Metformin and Polycystic Kidney Disease (PKD)
Metformin has also been investigated for its effects on autosomal dominant polycystic kidney disease (ADPKD). In a phase 2 trial, metformin was found to be safe and tolerable, with a slight reduction in the decline of estimated glomerular filtration rate (eGFR) compared to placebo, although the results were not statistically significant . This suggests that metformin may have a potential role in managing ADPKD, but larger trials are needed to confirm its efficacy.
Metformin and Kidney Cancer
Interestingly, metformin use has been associated with a decreased risk of kidney cancer in patients with T2DM. A study using data from the National Health Insurance in Taiwan found that metformin users had a significantly lower incidence of kidney cancer compared to non-users . This anticancer effect adds another dimension to the potential benefits of metformin on kidney health.
Conclusion
Overall, the current body of research suggests that metformin has multiple beneficial effects on kidney health, including protective roles in AKI, CKD, DKD, and potentially PKD and kidney cancer. While metformin is generally safe, caution is warranted in patients with advanced CKD due to the risk of lactic acidosis. Further research, particularly randomized controlled trials, is needed to fully elucidate the mechanisms and long-term benefits of metformin on renal function.
Sources and full results
Most relevant research papers on this topic